참고문헌
-
Baldwin, A. S. Jr. : The NF-
${\kappa}B$ and I${\kappa}B$ proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649 (1996). -
Kumar, A., Takada, Y., Boriek, A. M. and Aggarwal, B. B. : Nuclear factor-
${\kappa}B$ : its role in health and disease. J. Mol. Med. 82, 434 (2004). - Karin, M., Yamamoto, Y. and Wang, Q. M. : The IKK NFkappaB system: a treasure trove for drug development. Nature Reviews Drug Discovery 3, 17 (2004).
-
Finco, T. S. and Baldwin, A. S. : Mechanistic aspects of NF-
${\kappa}B$ regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263 (1995). -
Barnes, P. J. and Karin, M. : Nuclear factor-
${\kappa}B$ : a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066 (1997). - Sen, R. and Baltimore, D. : Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705 (1986).
- Kim, B. H., Reddy, A. M., Lee, K. H., Chung, E. Y., Cho, S. M., Lee, H., Min, K. R. and Kim, Y. : Inhibitory mechanism of chroman compound on LPS-induced nitric oxide production and nuclear factor-kappaB activation. Biochem. Biophys. Res. Commun. 325, 223 (2004).
-
Kwak, J. H., Won, S. W., Kim, T. J., Roh, E., Kang, H. Y., Lee, H. W., Jung, J. K., Hwang, B. Y., Kim, Y., Cho, J. and Lee, H. : Synthesis of chroman-2-carboxylic acid N-(substituted) phenylamides and their inhibitory effect on nuclear factor-
${\kappa}B$ (NF-${\kappa}B$ ) activation. Arch, Pharm. Res. 31, 133 (2008). - Skehan, P., Storeng, R., Scudiero, D. A., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R. : New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107 (1990).